Karen Sims - Net Worth and Insider Trading
Karen Sims Net Worth
The estimated net worth of Karen Sims is at least $349,378 dollars as of 2025-04-26. Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp and owns about 106,194 shares of Arbutus Biopharma Corp (ABUS) stock worth over $349,378. Details can be seen in Karen Sims's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Sims has not made any transactions after 2025-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Karen Sims
Karen Sims Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Sims owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of Karen Sims’s form 4 insider trades.
Insider Ownership Summary of Karen Sims
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ABUS | Arbutus Biopharma Corp | 2025-02-04 | Chief Medical Officer |
Karen Sims Latest Holdings Summary
Karen Sims currently owns a total of 1 stock. Karen Sims owns 106,194 shares of Arbutus Biopharma Corp (ABUS) as of February 4, 2025, with a value of $349,378.
Latest Holdings of Karen Sims
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | 2025-02-04 | 106,194 | 3.29 | 349,378 |
Holding Weightings of Karen Sims
Karen Sims Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Sims has made a total of 2 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 19,348 shares on February 4, 2025, which brought Karen Sims around $63,461.
Insider Trading History of Karen Sims
- 1
Karen Sims Trading Performance
Karen Sims Ownership Network
Ownership Network List of Karen Sims
Ownership Network Relation of Karen Sims

Karen Sims Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and General Counsel and CCO J. Christopher Naftzger .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Karen Sims made 2 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 23,706. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 33,954 shares made by Michael J. Mcelhaugh , a net sale of 31,776 shares made by David C Hastings , and a net sale of 11,333 shares made by J. Christopher Naftzger .
In summary, during the past 3 months, insiders sold 76,654 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 76,654 shares. During the past 18 months, 119,597 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,597 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Karen Sims Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Sims. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Karen Sims's mailing address is: Warminster Pa 18974.